Apcotex Industries (APCOTEXIND) Q4 03/04 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 03/04 earnings summary
23 Oct, 2026Executive summary
Gross sales rose 24.9% YoY to Rs.7,833.38 lakh, but PBT fell to Rs.13.19 lakh from Rs.183.55 lakh as higher input costs squeezed margins.
PAT was Rs.14.17 lakh versus Rs.88.09 lakh; EPS declined to Rs.0.26 from Rs.1.59.
A 10% dividend of Rs.1 per share was recommended; FY2004-05 outlook remained cautious amid rising raw-material prices and import competition.
Financial highlights
Gross sales increased 24.9% YoY to Rs.7,833.38 lakh from Rs.6,272.26 lakh; net sales after discounts, rebates and excise were Rs.6,533.16 lakh versus Rs.5,255.82 lakh.
PBT declined to Rs.13.19 lakh from Rs.183.55 lakh; PAT was Rs.14.17 lakh versus Rs.88.09 lakh.
Prior-year adjustments added Rs.26.81 lakh in FY2003-04 versus a Rs.9.51 lakh deduction in FY2002-03; period profit was Rs.40.98 lakh versus Rs.78.58 lakh.
Materials consumed rose to Rs.4,581.43 lakh from Rs.3,164.26 lakh, while manufacturing, administrative, selling and distribution expenses were Rs.1,355.43 lakh versus Rs.1,388.60 lakh.
Outlook and guidance
FY2004-05 was expected to be progressive for the economy, but operating conditions were projected to remain challenging as petroleum-linked raw-material prices rose.
Demand for everyday footwear, paper and board coatings, textiles, carpets and construction applications was expected to benefit from economic activity and consumer demand.
Technology upgrades, product innovation, quality consistency and development of additional product uses were identified as priorities for competitiveness.
Latest events from Apcotex Industries
- Record H1 earnings as volumes rose and Valia expansion advanced.APCOTEXIND
Q2 26/27 - Sales grew, but import-driven price pressure left a Rs 296.28 lacs net loss.APCOTEXIND
Q4 00/01 - Sales growth and new products drove a return to profit amid persistent competitive pressure.APCOTEXIND
Q4 01/02 - Sales advanced, but high petrochemical costs kept margins under pressure.APCOTEXIND
Q4 04/05 - Sales surged, but import competition squeezed margins and operating cash flow stayed negative.APCOTEXIND
Q4 99/00 - Sales and profits surged as the merger completed and export growth opportunities expanded.APCOTEXIND
Q4 17/18 - Sales and profit rebounded sharply, but rising input costs threaten margins.APCOTEXIND
Q4 07/08 - Sales and exports surged, but input volatility and FX exposure clouded the outlook.APCOTEXIND
Q4 11/12 - Sales rose 20%, profit increased, and capacity expansion moved ahead.APCOTEXIND
Q4 96/97